Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible

被引：12
|
作者：
Pointreau, Y. [1 ]
Lizee, T. [1 ,2 ]
Bensadoun, R. -J. [3 ]
Boisselier, P. [4 ]
Racadot, S. [5 ]
Thariat, J. [6 ]
Graff, P. [7 ]
机构：
[1] Ctr Jean Bernard, Inst Interreg Cancerol, Clin Victor Hugo, 9 Rue Beauverger, F-72000 Le Mans, France
[2] Inst Cancerol Ouest Paul Papin, 15 Rue Andre Boquel, F-49055 Angers 02, France
[3] Ctr Haute Energie, Inst Nicois Cancerol & Imagerie, 10 Blvd Pasteur, F-06000 Nice, France
[4] Inst Canc Montpellier, Dept Radiotherapie, 208 Ave Apothicaires,Parc Euromed, F-34298 Montpellier 5, France
[5] Ctr Leon Berard, Dept Radiotherapie, 28 Rue Laennec, F-69008 Lyon, France
[6] Ctr Antoine Lacassagne, Dept Radiotherapie, 33 Ave Valombrose, F-06189 Nice, France
[7] Inst Univ Canc Toulouse Oncopole, Serv Radiotherapie & Curietherapie, 1 Ave Irene Joliot Curie, F-31100 Toulouse, France
来源：
CANCER RADIOTHERAPIE | 2016年 / 20卷 / 6-7期
关键词：
Head and neck cancer; Intensity-modulated radiotherapy; Organ at risk; Mandible; Salivary gland; PATIENT-RATED XEROSTOMIA; PAROTID-GLAND; NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY; RETROSPECTIVE ANALYSIS; STICKY SALIVA; OSTEORADIONECROSIS; IRRADIATION; IMRT; MODELS;
D O I：
10.1016/j.canrad.2016.07.066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Intensity-modulated radiation therapy (IMRT) is the gold standard for head and neck irradiation. It allows better protection to the organs at risk such as salivary glands and mandible, and can reduce the frequency of xerostomia, trismus and osteoradionecrosis. At the time of treatment planning, the mean dose to a single parotid gland should be kept below 26 Gy, the mean dose to a single submandibular gland below 39 Gy, the mean dose to the mandible below 60 to 65 Gy and the D-2% to a single temporomandibular joint below 65 Gy. These dose constraints could be further improved with data extracted from cohorts of patients receiving IMRT exclusively. The dose administered to the target volumes should not be lessened to spare the salivary glands or mandible. (C) 2016 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：445 / 451
页数：7
相关论文
共 50 条
  • [31] Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy
    Loimu, Venla
    Seppala, Tiina
    Kapanen, Mika
    Tuomikoski, Laura
    Nurmi, Heidi
    Makitie, Antti
    Tenhunen, Mikko
    Saarilahti, Kauko
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 (02) : 178 - 184
  • [32] Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry
    Vallard, Alexis
    Guy, Jean-Baptiste
    Ndong, Sylvie Mengue
    Vial, Nicolas
    Rivoirard, Romain
    Auberdiac, Pierre
    Mery, Benoite
    Langrand-Escure, Julien
    Espenel, Sophie
    Moncharmont, Coralie
    Ben Mrad, Majed
    Diao, Peng
    Goyet, Dominique
    Magne, Nicolas
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (07): : 1028 - 1034
  • [33] Taste Function in PatientsWith Head and Neck Cancer Receiving Intensity-Modulated Radiotherapy
    Chen, Yi-Tzu
    Chou, Ying-Hsiang
    Wei, James Cheng-Chung
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (12) : 1184 - 1184
  • [34] REGIONAL RELAPSE AFTER INTENSITY-MODULATED RADIOTHERAPY FOR HEAD-AND-NECK CANCER
    Duprez, Frederic
    Bonte, Katrien
    De Neve, Wilfried
    Boterberg, Tom
    De Gersem, Werner
    Madani, Indira
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 450 - 458
  • [35] Intensity-modulated radiotherapy of head-and-neck cancer: Encouraging early results
    Eisbruch, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01): : 1 - 3
  • [36] Intensity-modulated radiotherapy in head and neck cancer - an update for oral and maxillofacial surgeons
    Brennan, P. A.
    Bradley, K. L.
    Brands, M.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (08): : 770 - 774
  • [37] Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy
    Münter, MW
    Karger, CP
    Hoffner, SG
    Hof, H
    Thilmann, C
    Rudat, V
    Nill, S
    Wannenmacher, M
    Debus, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (01): : 175 - 184
  • [38] MARGINAL MISSES AFTER POSTOPERATIVE INTENSITY-MODULATED RADIOTHERAPY FOR HEAD AND NECK CANCER
    Chen, Allen M.
    Farwell, D. Gregory
    Luu, Quang
    Chen, Leon M.
    Vijayakumar, Srinivasan
    Purdy, James A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1423 - 1429
  • [39] Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls
    Mendenhall, William M.
    Amdur, Robert J.
    Palta, Jatinder R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (17) : 2618 - 2623
  • [40] Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer
    Schoenfeld, Gordon O.
    Amdur, Robert J.
    Morris, Christopher G.
    Li, Jonathan G.
    Hinerman, Russell W.
    Mendenhall, William M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02): : 377 - 385
12345